Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial

Neurology. 2005 Sep 13;65(5):765-7. doi: 10.1212/01.wnl.0000174433.76707.8c.

Abstract

To compare autonomic effects of botulinum toxin (BTX), we randomized patients with cervical dystonia to receive either BTX-A or BTX-B in a double-blind manner. Efficacy and physiologic questionnaire measures of autonomic function were assessed at baseline and 2 weeks after injection. Patients treated with BTX-B had less saliva production (p < 0.01) and greater severity of constipation (p = 0.037) than those treated with BTX-A, but did not differ in other tests of autonomic functions.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Autonomic Nervous System / drug effects*
  • Autonomic Nervous System / physiopathology
  • Autonomic Nervous System Diseases / chemically induced*
  • Autonomic Nervous System Diseases / physiopathology
  • Botulinum Toxins / administration & dosage
  • Botulinum Toxins / adverse effects*
  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / adverse effects*
  • Cardiovascular Physiological Phenomena / drug effects
  • Cholinergic Fibers / drug effects*
  • Cholinergic Fibers / physiology
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Enteric Nervous System / drug effects
  • Enteric Nervous System / physiopathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuromuscular Agents / administration & dosage
  • Neuromuscular Agents / adverse effects
  • Presynaptic Terminals / drug effects
  • Presynaptic Terminals / physiology
  • Reflex, Pupillary / drug effects
  • Reflex, Pupillary / physiology
  • Respiratory Physiological Phenomena / drug effects
  • Salivation / drug effects
  • Torticollis / drug therapy*

Substances

  • Neuromuscular Agents
  • rimabotulinumtoxinB
  • Botulinum Toxins
  • Botulinum Toxins, Type A